Abstract
Insulin binding to its receptor leads to negatively cooperative interactions among the receptor sites. Studies with 29 insulin analogues (animal insulins and proinsulin, insulin-like growth factor and chemically modified insulins) which vary 1,000-fold in their affinity for the receptor and in their biological potency, suggest that a discrete invariable region on the surface of the insulin monomer is responsible for inducing the negative cooperativity. This domain comprises some of the eight carboxy-terminal residues of the B-chain and the A21 asparagine. Burying of this ‘cooperative site’ in the dimerisation of insulin leads to a loss of negative cooperativity. A revised mapping of the insulin molecule is proposed, featuring distinct bioactive and cooperative sites.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Freychet, P., Roth, J. & Neville, D. M., Jr Proc. natn. Acad. Sci. U.S.A. 68, 1833–1837 (1971).
Blundell, T. L., Dodson, G. G., Hodgkin, D. C. & Mercola, D. A. Adv. Protein Chem. 26, 279–402 (1972).
Wood, S. P., Blundell, T. L., Wollmer, A., Lazarus, N. R. & Neville, R. W. J. Eur. J. Biochem. 55, 531–542 (1975).
Pullen, R. A., Jenkins, J. A., Tickle, I. J., Wood, S. P. & Blundell, T. L. Molec. cell. Endocr. 8, 5–20 (1975).
Blundell, T. L. & Wood, S. P. Nature 257, 197–203 (1975).
Freychet, P., Brandenburg, D. & Wollmer, A. Diabetologia 10, 1–5 (1974).
Gliemann, J. & Gammeltoft, S. Diabetologia 10, 105–113 (1974).
Pullen, R. A. et al. Nature 259, 369–373 (1976).
Emdin, S. O., Gammeltoft, S. & Gliemann, J. Diabetologia 11, 340 (1975); J. biol. Chem. 252, 602–608 (1977).
Muggeo, M., Ginsberg, B. H., Roth, J., De Meyts, P. & Falkmer, S. Diabetes 26, Suppl. 1, 353 (1977).
De Meyts, P., Roth, J., Neville, D. M. Jr, Gavin, J. R., III & Lesniak, M. A. Biochem. biophys. Res. Commun. 55, 154–161 (1973).
De Meyts, P. J. supramolec. Struct. 4, 241–258 (1976).
De Meyts, P., Kahn, C. R., Ginsberg, B. & Roth, J. Diabetes 24, Suppl. 2, 393 (1975).
Schlesinger, J. & Levitzki, A. J. molec. Biol. 82, 547–561 (1974).
De Meyts, P., Bianco, A. R. & Roth, J. J. biol. Chem. 251, 1877–1888 (1976).
Gavin, J. R., III, Gorden, P., Roth, J., Archer, J. A. & Buell, D. N. J. biol. Chem. 248, 2202–2207 (1973).
De Meyts, P. in Methods in Receptor Research, Vol. 1 (ed. Blecher M ) 301–383 (M. Dekker, New York, 1976).
Gavin, J. R., III, Kahn, C. R., Gorden, P., Roth, J. & Neville, D. M., Jr J. clin. Endocr. Metab. 41, 438–445 (1975).
Kotaki, A. J. Biochem. 51, 301–309 (1962); 53, 61–70 (1963).
Smith, L. F. Am. J. Med. 40, 662–666 (1966).
Peterson, J. D., Coulter, C. L. & Steiner, D. F. Nature 251, 239–240 (1974).
Chance, R. E., Ellis, R. M. & Bromer, W. W. Science 161, 165–167 (1968).
Chance, R. G. in Proc. 7th Congr. Int. Diabetes Fedn, Buenos Aires, 1970 (eds Rodriguez, R. R. & Vallance-Owen, J.) Int. Congr. Ser. No. 231, 292–305 (Excerpta Medica, Amsterdam, 1971).
Lindsay, D. G. & Shall, S. Biochem. J. 121, 737–745 (1971).
Brandenburg, D. Hoppe-Seyler's Z. physiol. Chem. 350, 741–750 (1969).
Brandenburg, D. & Ooms, H. Excerpta med. Found. Int. Congr. Ser. 161, 482–484 (1968).
Africa, B. & Carpenter, F. H. Biochemistry 9, 1962–1972 (1970).
Carpenter, F. H. Am. J. Med. 40, 750–758 (1966).
Brandenburg, D., Gattner, H. G. & Wollmer, A. Hoppe-Seyler's Z. physiol. Chem. 353, 599–617 (1962).
Busse, W. D. & Carpenter, F. H. Biochemistry 15, 1649–1657 (1976).
Brandenburg, D. et al. in Proc. 7th Congr. Int. Diabetes Fedn, Buenos-Aires, 1970 (eds Rodriguez, R. R. & Vallance-Owen, J.) Int. Congr. Ser. No. 231, 363–376 (Excerpta Medica, Amsterdam, 1971).
Boesel, R. W. & Carpenter, F. H. Fedn Proc. 31, 255) 1972).
Rinderknecht, E. & Humbel, R. E. Proc. natn. Acad. Sci. U.S.A. 73, 4379–4381 (1976).
Brandenburg, D. et al. in Proc. 12th Eur. Peptide Symp. (eds Hanson, H. & Jakubke, H. D.) 270–283 (North-Holland, Amsterdam, 1973).
Wilson, A., Jakus, C. & Logan, L. 8th Congr. Int. Diabetes Fedn, Brussels, 1973, Abstr. Excerpta med. Int. Congr. Ser., No. 280, 136 (Excerpta Medica, Amsterdam, 1973).
The Shanghai Insulin Research Group Scientia sin. 16, 61–70 (1973).
Goldman, J. & Carpenter, F. H. Biochemistry 13, 4566–4574 (1974).
Zimmermann, A. E., Kells, D. I. C. & Yip, C. C. Biochem. biophys. Res. Commun. 46, 2127–2133 (1972).
Zimmermann, A. E. & Yip, C. C. J. biol. Chem. 249, 4021–4025 (1974).
Cuatrecasas, P. & Hollenberg, M. D. Biochem. biophys. Res. Commun. 62, 31–41 (1975).
Cutfield, J. F., Cutfield, S. M., Dodson, E. J., Dodson, G. G. & Sabesan, M. N. J. molec. Biol. 87, 23 (1974).
De Meyts, P. & Waelbroeck, M. Diabetes 26, Suppl. 1, 354 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meyts, P., Van Obberghen, E., Roth, J. et al. Mapping of the residues responsible for the negative cooperativity of the receptor-binding region of insulin. Nature 273, 504–509 (1978). https://doi.org/10.1038/273504a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/273504a0
This article is cited by
-
Determinants of IGF-II influencing stability, receptor binding and activation
Scientific Reports (2022)
-
Structural basis for the poisonous activity of a predator's venom insulin
Nature Structural & Molecular Biology (2016)
-
Harmonic oscillator model of the insulin and IGF1 receptors’ allosteric binding and activation
Molecular Systems Biology (2009)
-
Structural biology of insulin and IGF1 receptors: implications for drug design
Nature Reviews Drug Discovery (2002)
-
The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signalling
Diabetologia (1994)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.